AVALON PHARMACEUTICALS INC 4
4 · AVALON PHARMACEUTICALS INC · Filed Jun 1, 2009
Insider Transaction Report
Form 4
Carter Kenneth C
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Common Stock
2009-05-28−3,750→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2009-05-28−23,875→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger and Reorganization, dated October 27, 2008, as amended, between the issuer and Clinical Data, Inc., in exchange for (i) 0.0470 shares of Clinical Data's common stock per share of the issuer's common stock and (ii) a contingent value right representing the opportunity to receive up to an additional 0.01175 shares of Clinical Data's common stock per share of the issuer's common stock upon the achievement of certain defined milestones. Clinical Data's common stock had a market value of $11.99 per share at the close of business on the effective date of the merger.